175 related articles for article (PubMed ID: 12556205)
1. Analysing p53 tumour suppressor functions in mice.
Sluss HK; Jones SN
Expert Opin Ther Targets; 2003 Feb; 7(1):89-99. PubMed ID: 12556205
[TBL] [Abstract][Full Text] [Related]
2. Post-translational modification of p53 in tumorigenesis.
Bode AM; Dong Z
Nat Rev Cancer; 2004 Oct; 4(10):793-805. PubMed ID: 15510160
[TBL] [Abstract][Full Text] [Related]
3. RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome.
Stein T; Crighton D; Boyle JM; Varley JM; White RJ
Oncogene; 2002 May; 21(19):2961-70. PubMed ID: 12082526
[TBL] [Abstract][Full Text] [Related]
4. p53--an acrobat in tumorigenesis.
Moll UM; Schramm LM
Crit Rev Oral Biol Med; 1998; 9(1):23-37. PubMed ID: 9488246
[TBL] [Abstract][Full Text] [Related]
5. Gain-of-function mutations in the tumor suppressor gene p53.
van Oijen MG; Slootweg PJ
Clin Cancer Res; 2000 Jun; 6(6):2138-45. PubMed ID: 10873062
[TBL] [Abstract][Full Text] [Related]
6. Influence of tetramerisation on site-specific post-translational modifications of p53: comparison of human and murine p53 tumor suppressor protein.
Warnock LJ; Knox A; Mee TR; Raines SA; Milner J
Cancer Biol Ther; 2008 Sep; 7(9):1481-9. PubMed ID: 18769132
[TBL] [Abstract][Full Text] [Related]
7. Transcription-independent suppression of DNA synthesis by p53 in sperm-irradiated mouse zygotes.
Toyoshima M; Shimura T; Adiga SK; Taga M; Shiraishi K; Inoue M; Yuan ZM; Niwa O
Oncogene; 2005 May; 24(20):3229-35. PubMed ID: 15735681
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor p53: regulation and function.
Somasundaram K
Front Biosci; 2000 Apr; 5():D424-37. PubMed ID: 10762600
[TBL] [Abstract][Full Text] [Related]
9. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.
Falck J; Lukas C; Protopopova M; Lukas J; Selivanova G; Bartek J
Oncogene; 2001 Sep; 20(39):5503-10. PubMed ID: 11571648
[TBL] [Abstract][Full Text] [Related]
10. Signaling to p53: breaking the posttranslational modification code.
Appella E; Anderson CW
Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
[TBL] [Abstract][Full Text] [Related]
11. Strategies for manipulating the p53 pathway in the treatment of human cancer.
Hupp TR; Lane DP; Ball KL
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):1-17. PubMed ID: 11062053
[TBL] [Abstract][Full Text] [Related]
12. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?
Aubrey BJ; Kelly GL; Janic A; Herold MJ; Strasser A
Cell Death Differ; 2018 Jan; 25(1):104-113. PubMed ID: 29149101
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.
Sigal A; Rotter V
Cancer Res; 2000 Dec; 60(24):6788-93. PubMed ID: 11156366
[TBL] [Abstract][Full Text] [Related]
14. Posttranslational regulation of p53 tumor suppressor protein function.
Maxwell SA; Roth JA
Crit Rev Oncog; 1994; 5(1):23-57. PubMed ID: 7948107
[TBL] [Abstract][Full Text] [Related]
15. TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy.
Wang XW; Harris CC
Cancer Surv; 1996; 28():169-96. PubMed ID: 8977035
[TBL] [Abstract][Full Text] [Related]
16. Post-translational modifications and activation of p53 by genotoxic stresses.
Appella E; Anderson CW
Eur J Biochem; 2001 May; 268(10):2764-72. PubMed ID: 11358490
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
18. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
19. The subcellular distribution of the p53 tumour suppressor, and organismal ageing.
Wesierska-Gadek J; Schmid G
Cell Mol Biol Lett; 2005; 10(3):439-53. PubMed ID: 16217555
[TBL] [Abstract][Full Text] [Related]
20. Activation and activities of the p53 tumour suppressor protein.
Bálint E E; Vousden KH
Br J Cancer; 2001 Dec; 85(12):1813-23. PubMed ID: 11747320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
